Zenith Jove Peptide ZJ
Finnrick has tested 53 samples from Zenith Jove Peptide ZJ across 4 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 20 | 16 Dec 2025 | 25 May 2026 | |||||
| GHK-Cu | 5 | 20 Feb 2026 | 23 Apr 2026 | |||||
| BPC-157 | 6 | 6 Jan 2026 | 5 May 2026 | |||||
| Tirzepatide | 22 | 11 Dec 2025 | 5 May 2026 | |||||
The Zenith Jove Peptide ZJ samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 38 overall satisfaction reports
People who submitted test requests to Finnrick gave Zenith Jove Peptide ZJ an average satisfaction rating of 4.9 out of 5 across 38 reports associated with samples received and tested by Finnrick.
Most recent Zenith Jove Peptide ZJ tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 25 May 2026 | Retatrutide | View | 30mg | 31mg | +3.3% | 99.80% | S351 | Silver label / Silver crimp / Black cap | Lab G | Public | |
| 6 May 2026 | Retatrutide | View | 20mg | 19.4mg | -3.0% | 99.90% | RT20 | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 5 May 2026 | Retatrutide | View | 10mg | 10.4mg | +4.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 5 May 2026 | BPC-157 | View | 10mg | 10.5mg | +5.0% | 99.90% | BP10 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 5 May 2026 | Retatrutide | View | 10mg | 9.81mg | -1.9% | 99.90% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 5 May 2026 | Tirzepatide | View | 30mg | 29.5mg | -1.7% | 99.90% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 30mg | 27.2mg | -9.3% | 99.90% | (no batch ID) | No Label / Silver Crimp / Pink Cap | Lab E | Public | |
Corrections
- 25 Mar 2026: Tirzepatide
- Sample ef8mddf (Tirzepatide) and ryusy8h (Semaglutide) were reported by the submitter as mixed up, resulting in the incorrect test being run. However, Finnrick believes that such a mistake could have happened at the time of actually using the samples, because the vials are unlabeled, and therefore will not re-run the tests or retract the results, beyond the present note.
- 25 Mar 2026: Semaglutide
- Sample ef8mddf (Tirzepatide) and ryusy8h (Semaglutide) were reported by the submitter as mixed up, resulting in the incorrect test being run. However, Finnrick believes that such a mistake could have happened at the time of actually using the samples, because the vials are unlabeled, and therefore will not re-run the tests or retract the results, beyond the present note.
About Zenith Jove Peptide ZJ Test Results From Finnrick
Zenith Jove Peptide ZJ is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 4 products and 53 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Zenith Jove Peptide ZJ Testing Activity & Score Summary
In the past 30 days, Finnrick has published 6 new test results for Zenith Jove Peptide ZJ, and 23 in the past three months. The overall dataset includes 53 tested samples with an average score of 7.2/10 across all products.
Across 53 identity-tested samples, 98% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 100% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Tirzepatide (22 tests, 95% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 6.8/10), suggesting significant batch-to-batch differences.
- Retatrutide (20 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.4 to 10.0 (average 8.0/10), suggesting significant batch-to-batch differences.
- BPC-157 (6 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 3.8 to 10.0 (average 6.6/10), suggesting significant batch-to-batch differences.